Conference

 

 


The Advanced Therapies Congress is Europe’s largest commerical cell and gene therapy conference and exhibition. The event is for the leaders of pioneering ATMP companies and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.

In 2026, we’ll be bringing our community of 3,300 global executives back together once again at London’s ExCel, to be inspired by 300 speakers and 100 start-ups over 2 incredible days.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.  

 

OUR MISSION IS TO PROMOTE

  • The latest cutting-edge research entering the clinic
  • Safeguarding clinical success
  • Delivering cell and gene medicines to patients effectively
  • Scale up and automation of all processes and manufacturing
  • Scaling up from research to commercial levels
  • Moving beyond oncology applications
  • Addressing the bottleneck in potential business models and reimbursement
  • World leading technologies and solutions
  • A growing community of start-ups and disruptive technologies
 

Topics

 

Evidence, Pricing & Access
  • Ensuring clinical success
  • Tackling large scale regulatory challenges
  • Finding the right framework for reimbursement and market access
  • Cross-border healthcare
  • Outcome based agreements
  • Tackling large scale regulatory challenges
  • Patient informed policy decisions
Gene Modified Cell Therapy
  • Autologous vs allogeneic
  • Tackling solid tumours
  • Combination therapy
  • CAR-T, NK, Gamma-Delta cells
  • Patient stratification and precision medicine approaches
Cell Therapy
  • Stem cells
  • Regenerative Medicine
  • MSCs vs iPSCs
  • Cord blood advancements
Gene Therapy
  • Next generation of gene therapy
  • Moving from rare to more common diseases
  • Tackling immunogenicity
  • Rare diseases & orphan drugs
  • Novel gene delivery systems
  • Gene editing
Cell Therapy Manufacturing
  • Automation & closed systems
  • Scaling up to commercial level
  • Keeping costs low
  • In house vs outsourcing
Viral Vector Manufacturing
  • Continuous manufacturing
  • Scaling up for commercial production
  • In house vs outsourcing
Supply Chain & Logistics
  • Logistics, transportation, distribution & cold chain
  • Moving from clinical to commercial
  • Patient experience
  • Supply chain
  • Point of care delivery
Innovation Showcase
  • Latest in academic research
  • Latest cutting-edge technologies success

Advisory Board

 

We have a core group of leading ATMP experts who help us put together the agenda each year. With their expertise we build a programme with the most informative and up to date content each year.

 


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150